Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

• Status: Completed
• Trial end date: 2006-06-01

Summary

This study examines the effect of treatment of levodopa/entacapone on quality of life, as measured by the Parkinson's Disease-Questionnaire 8 (PDQ-8), in Parkinson's disease patients with no or minimal, non-disabling motor fluctuations.

• Phase: Phase 4

Details

• Lead Sponsor: Novartis
• Treatments: Carbidopa; Carbidopa, levodopa drug combination; Entacapone; Levodopa